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Atypical Presentation of Syphilis in an HTLV-I Infected Patient
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We report the case of a 44 year-old female, who presented a long-lasting, clinically atypical,
secondary syphilis (“malignant syphilis”) in the right foot, which started six months before
medical evaluation. The patient had a serological diagnosis of HTLV-I infection and syphilis two
years before the onset of the skin lesions, following a blood donation. As she believed she was
allergic to penicillin, she initially received sulfamethoxazole + trimethoprim, without any
improvement of the clinical picture. After failure of this first treatment regimen, she was given
penicillin, which promoted complete healing of the lesion. We found evidence that infection by
HTLV-I is capable of modifying the clinical course of secondary syphilis.
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Clinical manifestations of infection by human
lymphotropic virus type I (HTLV-I) often include skin
involvement, as seen in patients with infective
dermatitis, severe forms of scabies, and adult T-cell
leukemia/lymphoma [1-3]. It is also known that this
agent can cause a variable degree of immune
dysfunction, and this may modify the clinical
presentation of infections [1,4-6].
Syphilis is a treponemal infection that, if not treated,
can progress through four stages: primary (which usually
is oligosymptomatic), secondary, and late, which
includes central nervous system and cardiovascular
involvement. Secondary syphilis is generally latent, but
can present as a generalized and symmetrically
distributed maculopapular rash, which typically involves
palm and sole surfaces. [7].
Although there is experimental evidence showing
that the clinical course of syphilis can be altered in
animals infected by HTLV-I [8], we did not find any
previous report of such interaction in human beings.
We report a case of a woman infected by HTLV-I,
who developed an unusual presentation of secondary
syphilis.
Case Report
A 44 year-old female teacher who lives in Maceió, the
capital of Alagoas (a northeastern Brazilian state), asked
for medical assistance for skin lesions in the upper face of
her right foot, characterized by confluent, erythematous
papules and plaques which started about six months before
medical evaluation. She initially used a topical cream
containing steroids, without any improvement. She had
a serological diagnosis of HTLV-I two years before,
following a blood donation. In addition, she had had
a positive test for syphilis (VDRL=1:64), which was
initially treated with sulfamethoxazole plus
trimethoprim, since she reported allergy to penicillin.
Serology for HIV-1 and hepatitis B were negative.
She had never received blood products, and had no
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Six months before the onset of the skin lesion, the
patient presented with a vesicular eruption in the trunk,
diagnosed as herpes virus infection, which was
complicated by secondary bacterial infection. At that
time, a CD4/8  measurement showed 990 CD4+ cells/
mm3, and 656 CD8+ cells/mm3.
Dermatological examination: The patient presented
confluent and erythematous papules and plaques, with
small ulcers, on the dorsum of the right foot (Figure
1A), involving an area of 10 X 12 cm. Papules
displaying these same characteristics were seen at the
edges of the major lesions. She was initially diagnosed
as having larvae migrans infection, and was treated
with topical Thiabendazole. The lesion did not change
with this treatment, and she was submitted to a biopsy,
which revealed a pattern suggestive of secondary
syphilis. The patient received 2,400,000 IU Benzathine
Penicillin, intramuscularly, with a progressive
improvement of the lesion, and complete healing after
two months (Figure 1B).
Pathological report - The epidermis presented with
hyperkeratosis and mild atrophy. Throughout the
dermis, surrounding blood vessels, there was a
perivascular and periadnexal infiltration of lymphocytes
and plasma cells, sometimes associated with
granulomatous reactions (Figures 2A and 2B).
Discussion
Infection by HTLV-I causes neurological (HAM/
TSP), hematological (ATLL), and other types of diseases
(infectious dermatitis, uveitis, pneumonitis, etc.) [9].
However, over than 90% of patients infected by HTLV-
I do not present any clinical symptoms. Nevertheless,
some of these individuals show subclinical evidence of
immune dysfunction, which can modify the course of
some diseases, such as Strongyloides stercoralis
infection, and others [4,10].
Syphilis is an ancient, well-known, sexually
transmitted disease [7]. Although treatment of syphilis
is simple and efficacious, in patients with severe forms
of immunodeficiency (such as AIDS) it can be harder
to control, and can cause more severe forms of disease,
with frequent CNS involvement [11]. A severe form of
secondary syphilis, called “malignant syphilis” can occur
in HIV patients and in other immunodeficient conditions,
presenting as papulo-vesicular, pustular and necrotizing
lesions [12,13]. HTLV-I infection can cause some
degree of immune dysfunction, and thus could modify
the clinical course of syphilis.
The long lasting, localized and atypical eruption that
we found in our patient is not a usual finding in secondary
syphilis. However, the observed pattern of perivascular
granulomatous reaction is typical of long-lasting secondary
syphilis [14]. In an animal model, two out four rabbits
infected with HTLV-I and Treponema pallidum presented
with a protracted course of syphilis, when compared with
those that were not infected with HTLV-I, which showed
the usual course of infection, with rapid healing of skin
lesions. One animal needed to be treated with penicillin
after eight weeks of the challenge with T. pallidum,
suggesting defective cell-mediated immunity [8].
The unusual manifestation of syphilis in our patient
probably was a consequence of co-infection with
HTLV-I. The only immunological evaluation she was
submitted to showed a normal CD4/8 cell count, and a
negative PPD test. These findings do not preclude
immune dysfunction, since CD4/8 values are often
normal, or even increased, in patients infected by
HTLV-I, and a negative PPD test cannot be taken as
conclusive evidence of an altered immune response.
In conclusion, we found evidence that infection by
HTLV-I can modify the natural course of syphilis. The
usual syphilis treatment regimen seems to works as well
in co-infected patients.
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Figure 1A. Confluent and erythematous papules and plaques on the dorsum of the right foot, some of them with
shallow ulcers.
Figure 1B. Aspect of skin lesion in the right foot, after treatment.
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Figure 2A. Granulomatous reaction with epithelioid cells. HE, A 200.
Figure 2B. A moderate perivascular and periadnexal infiltrate of lymphocytes and plasma cells in the deep
dermis. HE, A 160.
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